Articles On Telix Pharmaceuticals (ASX:TLX)

This article is part of the daily news updates from FNArena.com. Stay informed with the latest financial, business, and economic insights. Written by Admin MELBOURNE, Australia and INDIANAPOLIS, Ind., March 4, 2025 /PRNewswire/ — Telix P...

ASX 200 healthcare share Telix Pharmaceuticals Ltd (ASX: TLX) fell 9.4% to an intraday low of $27.52 as the market digested news of a $118 million off-market trade by the co-founders. The radiopharmaceutical company's CEO, Dr. Christian...

In afternoon trade, the S&P/ASX 200 Index (ASX: XJO) is on course to end the week deep in the red. At the time of writing, the benchmark index is down 0.75% to 8,205.8 points. Four ASX shares that are falling more than most today are l...

Highlights: Karoon Energy strengthens its operational framework with an asset acquisition for its Brazil-based project. Qantas announces a dividend reinstatement, reflecting financial recovery in the aviation sector. Fluctuations...

Good afternoon and welcome to the Thursday edition of Market Close, I’m Jonathon Davidson. It was a somewhat happier day as Australian icon Qantas paid its first dividend in years and household name Coles proved to be consistently growing....

Highlights  Strong Start: ASX opens higher, driven by consumer staples and aviation sectors.  Corporate Moves: Notable stock movements include (ASX:COL), (ASX:QAN), (ASX:RHC), and (ASX:IDP).  Tech Sector Volatility: Nvidia’s earnings...

This article is part of the daily news updates from FNArena.com. Stay informed with the latest financial, business, and economic insights. Written by Admin SPI futures are signalling yet anolther uninspiring, downbeat session lays ahead for...

This article is part of the daily news updates from FNArena.com. Stay informed with the latest financial, business, and economic insights. Written by Admin MELBOURNE, Australia, Feb. 26, 2025 /PRNewswire/ – Telix Pharmaceuticals Limited...

This article is part of the daily news updates from FNArena.com. Stay informed with the latest financial, business, and economic insights. Written by Admin SPI futures are suggesting another cautious, slightly weaker opening for the ASX tod...

Like London buses, takeovers tend to come in a rush Mayne Pharma had struggled for years, but its performance was improving Takeovers in the ASX biotech sector have been few and far between The ‘London’ Bus theory goes that if one takeove...

Right now, I own Pro Medicus Ltd (ASX: PME) shares, Resmed CDI(ASX: RMD) shares and Telix Pharmaceuticals Ltd (ASX: TLX) shares, and previously owner Xero Ltd (ASX: XRO) shares. This article explains why I own PME, RMD and TLX, and some of...

S&P/ASX 300 Index (ASX: XKO) shares are currently down 0.66% to 8,185.70 points. Meantime, several companies in the index have hit new share price highs today. ASX 300 shares setting new price records on Tuesday Telix Pharmaceu...

The ASX is cruising along in 2025, extending a solid run for the S&P/ASX 200 Index (ASX: XJO). In the past year, it has climbed 655 points, or more than 8.5%. According to the experts, investors searching for shares with even greate...

This article is part of the daily news updates from FNArena.com. Stay informed with the latest financial, business, and economic insights. Written by Admin Australian shares are set to open lower following a choppy session on Wall Street, a...

This article is part of the daily news updates from FNArena.com. Stay informed with the latest financial, business, and economic insights. Written by Admin Welcome to the FNArena Corporate Results Monitor. Today's Reports: ((AX1)) - Accen...

It's been a wild start to the trading week this Monday for ASX investors. After taking a deep plunge at market open this morning, the S&P/ASX 200 Index (ASX: XJO) and many ASX 200 stocks have since recovered. The index has currently bro...

With so many shares to choose from on the Australian share market, it can be difficult to decide which ones to buy. The good news is that brokers across the country are doing a lot of the hard work for you. Three top ASX shares that leading...

Telix expects three more US product approvals this year Patrys switches to plan B Biotron’s do-or-die $500,000 capital raising   Analysts reckon Telix Pharmaceuticals (ASX:TLX) has only just started to reach its full potential, with three...

Telix Pharmaceuticals Ltd (ASX: TLX) shares have been on an absolute tear over the past year, surging an incredible 175%. And according to the team at Bell Potter, this high-flying ASX 200 share may have even more room to run. This morning,...

It was a disappointing end to a horrid trading week for the S&P/ASX 200 Index (ASX: XJO). After falling every day this week, the ASX 200 capped off Friday's session with a 0.32% sell-down. Tha...

ASX hovers near one-month low, dragged by GYG and banks Domain soars on takeover bid RBA’s bullock admits slow rate hikes, while Alibaba rebounds   The ASX had a rough afternoon on Friday, with the market closing near its one-month low. D...

Highlights  ASX 200 edges lower as consumer discretionary stocks struggle.  Commonwealth Bank (ASX:CBA) and major banks face downward pressure.  Domain (ASX:DHG) surges on takeover speculation, while REA Group (ASX:REA) drops.  Th...

The S&P/ASX 200 Index (ASX: XJO) is rebounding slightly from yesterday's selloff. At the time of writing, the benchmark index is up 0.15% to 8,335.9 points. Four ASX shares that are rising more than most today are listed below. Here's...

Highlights  S&P 500 declines: The index retreats from record highs following weak Walmart guidance and renewed tariff concerns.  ASX 200 futures rise: Local markets set for a rebound after three consecutive sessions of declines. ...

The Telix Pharmaceuticals Ltd (ASX: TLX) share price is racing higher on Friday morning. At the time of writing, the pharmaceutical company's shares are up 13% to a record high of $30.00. This follows the release of its full year results af...

On Thursday, the S&P/ASX 200 Index (ASX: XJO) had a very disappointing session and dropped deep into the red. The benchmark index fell 1.15% to 8,322.8 points. Will the market be able to bounce back from this on Friday and end the wee...

This article is part of the daily news updates from FNArena.com. Stay informed with the latest financial, business, and economic insights. Written by Admin MELBOURNE, Australia and INDIANAPOLIS, Ind., Feb. 20, 2025 /PRNewswire/ – Telix P...

S&P/ASX 200 Index (ASX: XJO) healthcare stock Telix Pharmaceuticals Ltd (ASX: TLX) has delivered some smashing returns to shareholders, both over the short and long term. And it looks well-placed to continue outperforming. Shares in th...

Highlights Several ASX-listed biotech companies are nearing FDA approval, signifying potential entry into the crucial U.S. market. The FDA has improved its communication with applicants, fostering a more predictable approval process....

Highlights  ASX 200 Futures remained steady, up 2 points (+0.02%) as of 8:30 am AEDT, signaling a cautious market open.  Commonwealth Bank of Australia (ASX:CBA) reported first-half FY25 net profit after tax (NPAT) growth of 2%, slight...

Having lodged their paperwork, companies including EBR Systems, Artyra and Orthocell await crucial FDA approval The agency has improved its communications with applicants, which avoids nasty surprises Applicants are doing the commercial gr...

ASX 200 healthcare shares are up 0.47% amid a strong day for the Australian share market. The benchmark S&P/ASX 200 Index (ASX: XJO) is up 1.05% at the time of writing, as the first week of earnings season continues on Thursday....

The S&P/ASX 200 Index (ASX: XJO) snatched defeat from the jaws of victory today, letting an early surge slip away to finish slightly lower. Despite rising as much as 0.8% this morning, the ASX...

After the tariff-induced carnage that kicked off the trading week yesterday, the S&P/ASX 200 Index (ASX: XJO) and many ASX 200 stocks are bouncing back this Tuesday. At the time of writing, the index has added a healthy 0.43% and is bac...

It's been a great session for S&P/ASX 200 Index (ASX: XJO) stocks so far this Wednesday. At the time of writing, the ASX 200 has climbed by 0.85%, leaving the index at around 8,470 points. Although this hasn't quite lifted the ASX 20...

It was a wild and woolly start to the short trading week for the S&P/ASX 200 Index (ASX: XJO) and most ASX shares this Tuesday. After an initial plunge this morning, the ASX 200 managed to rec...

S&P/ASX 200 Index (ASX: XJO) stocks are trading just inside the green at 8,419.7 points in late afternoon trade on Tuesday. The ASX 200 dipped then flipped in early trading after a sell-off on Wall Street overnight. The benchmark...

The ASX200 has been up 0.06% at 8,414 points. The tech sector has been heavily sold off as global markets respond to the rise of Deepseek, China’s AI startup. Discretionary has been the best performing sector, up 1.2%, followed by Tel...

Telix Pharmaceuticals (ASX:TLX) has joined a somewhat quiet cohort of ASX biotech companies having a pretty good run lately, in some cases outperforming just about everything else. (Just think: Mesoblast, Orthocell, Clarity Pharmaceutica...

The S&P/ASX 200 Index (ASX: XJO) has fought back from a poor start and is pushing higher. In early afternoon trade, the benchmark index is up 0.2% to 8,425.7 points. Four ASX shares that are rising more than most today are listed below...

The ASX 200 is rumbling back to life after the Australia Day long weekend and investors are pushing the bourse up by over 37.9 points already. The 0.45% rise, to around 8,417 points, stands in defiance to the tech rout Wall Street suffer...

This article is part of the daily news updates from FNArena.com. Stay informed with the latest financial, business, and economic insights. Written by Admin MELBOURNE, Australia and INDIANAPOLIS, Jan. 28, 2025 /PRNewswire/ — Telix Pharmac...

The S&P/ASX 200 Index (ASX: XJO) is down 0.7% in early afternoon trade on Thursday, but that's not keeping these four ASX 200 shares from leaping to new 52-week highs. Two of the outperforming companies operate in the healthcare spa...

Viewed as a ‘mini me’ version of the all-conquering Telix Pharmaceuticals, the $60 million market cap Radiopharm Theranostics (ASX:RAD) is emerging from unloved status to that of a genuine contender in the red-hot radiopharmaceutical sector...

The ASX200 closed down 0.2% at 8,310 points. China’s latest economic data beat estimates. GDP growth accelerated to 5.4 per cent year-over-year for the December quarter, up from 4.6 per cent in the September quarter and well above con...

Banks fall, mining stocks rise Rio Tinto in mega merger talks, suggests Bloomberg China hits 5pc growth but property struggles   After a day of zigzagging, the ASX closed lower by 0.2% on Friday as losses in the financials and comms secto...

Announced today, Melbourne-based biotech Telix Pharmaceuticals (ASX: TLX) is a step closer to launching its prostate cancer diagnostic agent Illuccix in Europe after securing authorisation for its commercial distribution. The company annou...

Highlights  Commonwealth Bank (ASX:CBA) drags down ASX after major losses.  Lovisa (ASX:LOV) jumps 8% following an upgrade to “overweight” rating.  Lynas Rare Earths (ASX:LYC) dips 2.2% due to slower production.  On Friday afterno...

After the ASX’s strong performance in 2024, optimism is building as we shift our focus to what 2025 has in store. The New Year brings renewed energy, exciting opportunities, and the promise of growth. But the big question is: will the marke...

Highlights  S&P/ASX 200 index remains flat at midday.  Rio Tinto (ASX:RIO) slips, while Insignia Financial (ASX:IFL) rises after a bid increase.  Lynas Rare Earths (ASX:LYC) sees a dip following production slowdown.  Australia...